Altered molecular pathways in melanocytic lesions

International Journal of Cancer

Volumn 126, Issue 8, 2010, Pages 1869-1881

  Scatolini, Maria ^c   Grand, Maurizia Mello ^c   Grosso, Enrico ^c   Venesio, Tiziana ^a   Pisacane, Alberto ^a   Balsamo, Antonella ^a   Sirovich, Roberta ^b   Risio, Mauro ^a   Chiorino, Giovanna ^c  

^a CANDIOLO CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Laboratory of Cancer Genomics   (Italy)

Author keywords

Dysplastic nevus; Gene profiling; Melanoma progression

Indexed keywords

ADULT; AGED; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL ADHESION; CELL JUNCTION; CELL PROLIFERATION; COMMON NEVI; DETOXIFICATION; DOUBLE STRANDED DNA BREAK; DOWN REGULATION; DYSPLASTIC NEVUS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MICROARRAY ANALYSIS; MISMATCH REPAIR; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; PIGMENTED NEVUS; PRIORITY JOURNAL; SKIN BIOPSY; SKIN METASTASIS; T LYMPHOCYTE ACTIVATION; TUMOR BIOPSY; UPREGULATION; DNA MICROARRAY; GENE EXPRESSION; GENETICS; MIDDLE AGED; NEVUS; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN TUMOR;

ADULT; AGED; APOPTOSIS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEVUS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS;

EID: 77949876566     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24899     Document Type: Article

References (22)

1. Lomas J, Martín-Duque P, Pons M, Quintanilla M. The genetics of malignant melanoma. Front Biosci 2008; 13:5071-5093
2. Singh M, Lin J, Hocker TL, Tsao H, Genetics of melanoma tumorigenesis. Br J Dermatol 2008; 158:15-21.
3. Clark WH, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969; 29:705-727
4. Dahl C, Guldberg P. The genome and epigenome of malignant melanoma. APMIS 2007; 115:1161-1176
5. Chiorino G, Mello Grand M, Scatolini M, Ostano P. From single gene to integrative molecular concept maps: pitfalls and potentials of microarray technology. J Biol Regul Homeost Agents 2008; 22:7-16.
6. Hoek KS. DNA microarray analyses of melanoma gene expression: a decade in the mines. Pigment Cell Res 2007; 20:466-484
7. Haqq C, Nosrati M, Sudilovsky D, Crothers J, Khodabakhsh D, Pulliam Bl, Federman S, Miller JR, III, Allen Re, Singer Mi, Leong Sp, Ljung Bm, et al. The gene expression signatures of melanoma progression. Proc Natl Acad Sci USA 2005; 102:6092-6097
8. Smith Ap, Hoek K, Becker D. Wholegenome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas, Cancer Biol Ther 2005; 4: 1018-1029
9. Jaeger J, Koczan D, Thiesen HJ, Ibrahim SM, Gross G, Spang R, Kunz M. Gene expression signatures for tumorprogression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues. Clin Cancer Res 2007; 13:806-815
10. Elder DE, Clark WH, Elenitsas R, Guerry DT, Halpern AC. The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi. Semin Diagn Pathol 1993; 10:18-35.
11. Leboit Pe, Burg G, Weedon D, Sarasin A. WHO classification of tumors, pathology Sc genetics, skin tumours. Lyon: IARC Press, 2006.
12. Venesio T, Chiorino G, Balsamo A, Zaccagna A, Petti C, Scatolini M, Pisacane A, Sarotto I, Picciotto F, Risio M, In melanocytic lesions the fraction of BRAF V600E alieles is associated with sun exposure but unrelated to ERK phosphorylation. Mod Pathol 2008; 21: 716-726
13. Kerr JF, Wyllie AH, Currie AR, Apoptosis: a basic biological phenomenon with wideranging implications in tissue kinetics. Br J Cancer 1972; 26:239-257
14. Smyth GK, Speed T, Normalization of cDNA microarray data. Methods 2003; 31: 265-273
15. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3:Article 3.
16. Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, Holloway A, Smyth. GK. A comparison of background correction methods for two-colour microarrays. Bioinformatics 2007; 23:2700-2707
17. Hidaka K, Caffrey JJ, Hua L, Zhang T, Falck JR, Nickel GC, Carrel L, Barnes LD, Shears SB. An adjacent pair of human NUDT genes on chromosome X are preferentially expressed in testis and encode two new isoforms of diphosphoinositol polyphosphate phosphohydrolase. J Biol Chem 2002; 277: 32730-32738
18. McCarthy MM, Pick E, Kluger Y, GouldRothberg B, Lazova R, Camp RL, Rimm DL, Kluger HM. HSP90 as a marker of progression in melanoma. Ann Oncol 2008; 19:590-594
19. Cui Y, Liao YC, Lo SH.Epidermal growth factor modulates tyrosine phosphorylation of a novel tensin family member, tensin3, Mol Cancer Res 2004; 2:225-232
20. Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 2008; 1:13.
21. Khambata-Ford S, Garrett CR, Meropol NJ, Basik M, Harbison CT, Wu S, Wong TW, Huang X, Takimoto CH, Godwin AK. Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. J Clin Oncol 2007; 25:3230-3237
22. Wang Z, Cao Y, Albino AP, Zeff RA, Houghton A, Ferrone S. Lack of HLA class I antigen expression by melanoma cells SK-M.EL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA. J Clin Invest 1993; 91:684-692